9SK-29396-52727
1 vaccination
3 coded responses
9 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 472 / IN
- Registered
- 2022-01-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-25
Registered in v-safe
-
2022-01-25
Dose 1 — Pfizer-BioNTech
- 2022-01-25
- 2022-01-26
-
2022-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: Fair · HeadacheFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-28
- 2022-01-29
-
2022-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Chest pain — Feeling: Poor · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Chest painMedDRA releases: 2024-11 · check-in free text available
-
2022-02-01
Survey response — day 7, dose 1MedDRA: Ageusia, Anosmia — Feeling: Fair · Headache, Fatigue or tirednessFree text: No smell or tasteMedDRA releases: 2024-11 · check-in free text available
- 2022-02-10
- 2022-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-25 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat
Systemic reaction (other): Chest pain
Release 11 — day 7, dose 1
Systemic reaction (other): No smell or taste
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Ageusia | · | · | ✓ |
| SRO | Anosmia | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release